have found that CD70 ablation in primary GBM cell lines can reduce the expressions of CD44 and SOX2 genes, inhibiting the tumor migration, growth, and ability to attract monocyte-derived M2 macrophages in vitro (71). Here, SOX2 is linked to glioblastoma.